Last edition
News about " CDMO Performance and Global Expansion Plans"
In Q1 FY26, Akums posted total income of INR 1,051 crore and adjusted EBITDA of INR 156 crore, reflecting a 19.1% year-on-year increase. EBITDA margins improved to 14.8%, up from 12.7% last year — a 208-basis-point gain.
CDMO Performance And Global Expansion Plans | 11/08/2025 | By Darshana | 291
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members